Page last updated: 2024-10-16

gamma-aminobutyric acid and Devic Disease

gamma-aminobutyric acid has been researched along with Devic Disease in 2 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Yang, Y1
Rui, Q1
Han, S1
Wu, X1
Wang, X1
Wu, P1
Shen, Y1
Dai, H1
Xue, Q1
Li, Y1
Miao, J1
Aboagye, DE1
Chulpayev, B1
Liu, L1
Ishkanian, G1
Kolanuvada, B1
Alaie, D1
Petrillo, RL1

Other Studies

2 other studies available for gamma-aminobutyric acid and Devic Disease

ArticleYear
Reduced GABA levels in the medial prefrontal cortex are associated with cognitive impairment in patients with NMOSD.
    Multiple sclerosis and related disorders, 2022, Volume: 58

    Topics: Cognitive Dysfunction; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Magnetic Resonance Imaging; M

2022
Importance of Regular and Maintenance Therapy Adherence in Neuromyelitis Optica (NMO): Lessons from a Repeating Relapse Case.
    The American journal of case reports, 2018, Jan-11, Volume: 19

    Topics: Amines; Analgesics; Autoantibodies; Biomarkers; Chronic Disease; Cyclohexanecarboxylic Acids; Female

2018